M4MM

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Rubicon Organics Reports Q2 2024 Financial Results

LOS ANGELES- Rubicon Organics Inc. a licensed producer specializing in organic and premium cannabis, released its financial results for the second quarter ending June 30, 2024. The company reported record net revenue of CAD 12.1 ...

Filament Health Reports Q2 2024 Results

LOS ANGELES- Filament Health Corp, a clinical psychedelic drug development company, has released its financial results for the second quarter ending June 30, 2024. The company highlighted its progress in advancing drug candidates targeting substance ...

Subscribe To Our Newsletter